Follow us:Follow Us on Twitter Like Us on Facebook Follow Us on Google+ Watch videos on our Youtube channel
Cedars-Sinai Heart Institute is currently conducting the following Congestive Heart Failure Clinical Research trials:
- Observational Review of Clinical Outcomes in Heart Failure Patients Undergoing Bariatric Surgery
- Parachute IV
IRB Approval No.: 29045
Contact: Maria Thottam, Study Coordinator, (310) 248-7132
Project Summary: Obesity in those with advanced heart failure limits their treatment options, as guidelines supports that a BMI of < 30 kg/m2 is recommended prior to listing for cardiac transplantation. Weight reduction is therefore essential for survival in those with advanced heart failure, although due to the obesity paradox, it remains unclear if weight loss is harmful in this population. Further studies are therefore needed not only to clarify the impact of decreased weight in patients with advanced HF, but to provide the appropriate management of these patients in order avoid worsening outcomes and offer all therapeutic options available. This is an observational study to evaluate the safety and feasibility of bariatric surgery in high risk obese patients with heart failure and its impact on cardiac function and functional status. Twenty patients will be enrolled in this study and their participation is expected to last two years. After having bariatric surgery, heart failure cardiologists will observe patients' progress following the surgery.